Azenta (AZTA) | Financial Analysis & Statements
Azenta Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
148.6M
Gross Profit
63.7M
42.86%
Operating Income
-6.1M
-4.10%
Net Income
-15.4M
-10.38%
EPS (Diluted)
$-0.34
Balance Sheet Metrics
Total Assets
2.1B
Total Liabilities
332.6M
Shareholders Equity
1.7B
Debt to Equity
0.19
Cash Flow Metrics
Operating Cash Flow
-1.2M
Free Cash Flow
-5.7M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Azenta Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 593.8M | 656.3M | 665.1M | 555.5M | 513.7M |
| Cost of Goods Sold | 323.5M | 393.0M | 401.9M | 299.9M | 269.9M |
| Gross Profit | 270.3M | 263.4M | 263.1M | 255.6M | 243.8M |
| Gross Margin % | 45.5% | 40.1% | 39.6% | 46.0% | 47.5% |
| Operating Expenses | |||||
| Research & Development | 30.4M | 33.5M | 34.0M | 27.5M | 22.4M |
| Selling, General & Administrative | 261.6M | 302.7M | 316.3M | 251.5M | 252.1M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 292.0M | 336.3M | 350.2M | 279.0M | 274.5M |
| Operating Income | -21.7M | -72.9M | -87.1M | -23.4M | -30.7M |
| Operating Margin % | -3.6% | -11.1% | -13.1% | -4.2% | -6.0% |
| Non-Operating Items | |||||
| Interest Income | 18.8M | 33.2M | 43.7M | 15.7M | 632.0K |
| Interest Expense | - | - | 0 | 4.6M | 2.0M |
| Other Non-Operating Income | -4.2M | -127.6M | 12.9M | -2.2M | -16.9M |
| Pre-tax Income | -7.1M | -167.3M | -30.4M | -9.9M | -49.0M |
| Income Tax | -31.6M | -3.2M | -17.6M | 1.4M | -20.1M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -55.8M | -164.2M | -14.3M | 2.1B | 110.7M |
| Net Margin % | -9.4% | -25.0% | -2.1% | 384.0% | 21.6% |
| Key Metrics | |||||
| EBITDA | 44.7M | 145.6M | -15.5M | 31.6M | 18.8M |
| EPS (Basic) | $-1.30 | $-3.60 | $-0.22 | $28.48 | $1.49 |
| EPS (Diluted) | $-1.30 | $-3.60 | $-0.22 | $28.48 | $1.49 |
| Basic Shares Outstanding | 45743000 | 45570084 | 66253000 | 74897000 | 74229000 |
| Diluted Shares Outstanding | 45743000 | 45570084 | 66253000 | 74897000 | 74229000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Azenta Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 279.8M | 310.9M | 678.9M | 658.3M | 227.4M |
| Short-term Investments | 61.1M | 151.2M | 338.9M | 911.8M | 81.0K |
| Accounts Receivable | 142.2M | 172.7M | 156.5M | 163.8M | 119.9M |
| Inventory | 75.0M | 115.3M | 128.2M | 85.5M | 60.4M |
| Other Current Assets | 64.7M | 80.7M | 98.8M | 132.6M | 51.1M |
| Total Current Assets | 708.3M | 832.8M | 1.4B | 2.5B | 777.4M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 54.0M | 69.5M | 71.3M | 2.5M | 2.3M |
| Goodwill | 1.5B | 1.6B | 1.9B | 1.2B | 1.1B |
| Intangible Assets | 101.8M | 248.0M | 294.3M | 178.4M | 186.5M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 137.4M | 11.7M | 4.5M | 58.3M | 251.9M |
| Total Non-Current Assets | 1.4B | 1.3B | 1.5B | 1.3B | 1.0B |
| Total Assets | 2.1B | 2.1B | 2.9B | 3.7B | 1.8B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 37.7M | 44.4M | 35.8M | 38.7M | 42.4M |
| Short-term Debt | - | - | - | - | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 61.7M | - | - | - | 128.9M |
| Total Current Liabilities | 237.7M | 204.8M | 210.9M | 230.5M | 345.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 51.2M | 58.8M | 60.4M | 49.2M | 94.8M |
| Deferred Tax Liabilities | 18.2M | 54.6M | 67.7M | 66.2M | 15.0M |
| Other Non-Current Liabilities | 11.1M | 12.9M | 12.2M | 6.7M | 6.2M |
| Total Non-Current Liabilities | 94.9M | 126.2M | 140.3M | 122.2M | 149.1M |
| Total Liabilities | 332.6M | 331.1M | 351.2M | 352.7M | 494.2M |
| Equity | |||||
| Common Stock | 594.0K | 590.0K | 713.0K | 885.0K | 878.0K |
| Retained Earnings | 1.4B | 1.5B | 1.6B | 1.7B | -470.1M |
| Treasury Stock | 201.0M | 201.0M | 201.0M | 201.0M | 201.0M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.7B | 1.8B | 2.5B | 3.4B | 1.3B |
| Key Metrics | |||||
| Total Debt | 51.2M | 58.8M | 60.4M | 49.2M | 94.8M |
| Working Capital | 470.7M | 628.0M | 1.2B | 2.2B | 432.3M |
Balance Sheet Composition
Azenta Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -55.8M | -164.2M | -14.3M | 2.1B | 110.7M |
| Depreciation & Amortization | 61.2M | 90.7M | 85.6M | 53.7M | 65.3M |
| Stock-Based Compensation | 20.9M | 14.5M | 9.4M | 10.7M | 27.5M |
| Working Capital Changes | -29.8M | 7.9M | -13.7M | -84.4M | -58.6M |
| Operating Cash Flow | -30.5M | -62.8M | 29.5M | 2.1B | 127.7M |
| Investing Activities | |||||
| Capital Expenditures | -33.9M | -37.4M | -39.4M | -73.4M | -52.8M |
| Acquisitions | 0 | 0 | -386.5M | 2.8B | -95.5M |
| Investment Purchases | -451.4M | -405.6M | -236.2M | -2.0B | -151.0K |
| Investment Sales | 394.8M | 667.7M | 1.1B | 705.4M | 121.0K |
| Investing Cash Flow | -90.5M | 224.7M | 431.4M | 1.5B | -146.3M |
| Financing Activities | |||||
| Share Repurchases | 0 | -661.7M | -838.5M | 0 | 0 |
| Dividends Paid | - | 0 | 0 | -7.5M | -29.7M |
| Debt Issuance | - | - | - | - | 0 |
| Debt Repayment | -985.0K | -783.0K | -578.0K | -50.1M | -2.0M |
| Financing Cash Flow | -9.6M | -659.2M | -840.5M | -62.8M | -25.9M |
| Free Cash Flow | 38.3M | 12.9M | -32.3M | -543.5M | 97.1M |
| Net Change in Cash | -130.6M | -497.3M | -379.6M | 3.5B | -44.5M |
Cash Flow Trend
Azenta Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
45.40
Forward P/E
24.11
Price to Book
0.71
Price to Sales
2.04
PEG Ratio
2.63
Profitability Ratios
Profit Margin
-10.12%
Operating Margin
-4.10%
Return on Equity
1.53%
Return on Assets
-0.59%
Financial Health
Current Ratio
2.92
Debt to Equity
3.18
Beta
1.46
Per Share Data
EPS (TTM)
$0.58
Book Value per Share
$37.26
Revenue per Share
$12.99
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| AZTA | 1.2B | 45.40 | 0.71 | 1.53% | -10.12% | 3.18 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Pulse Biosciences | 1.6B | - | 20.17 | -74.45% | -54.00% | 9.34 |
| AtriCure | 1.4B | -117.54 | 2.77 | -2.40% | -2.14% | 15.54 |
| Staar Surgical | 1.2B | 49.73 | 3.58 | -21.70% | -33.60% | 11.14 |
Financial data is updated regularly. All figures are in the company's reporting currency.






